The findings suggest that the research conducted will be useful in enhancing the development of the HIV vaccine and can also be used to improve other viral pathogens.
Kennedy Ferruggia, Associate Editor
Advertisement
Kennedy Ferruggia is an associate editor at Pharmacy Times®. She graduated from The College of New Jersey in 2023 in journalism and marketing. Prior to this position, she worked as a pharmacy associate for community pharmacies.
Articles by Kennedy Ferruggia, Associate Editor
Utilizing longitudinal assessments of language impairment and clinical progression could help identify challenges earlier.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Predictive Models Could Address Missing Data in Advanced Prostate Cancer
2
Ivonescimab Significantly Extends OS Over Pembrolizumab in PD-L1-Positive Advanced NSCLC
3
FDA Approves Apitegromab-mstn, First Muscle-Targeted SMA Therapy
4
CGM and Ketone Data Reshape Pharmacist-Led Diabetes Care: Insights From NEIAP 2026
5